Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)

Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)

Background: Activated phosphoinositide 3-kinase (PI3K) δ Syndrome (APDS) is an ultra-rare, potentially life-threatening disease that lacks approved treatments in Spain. This study aimed to apply Multi-Criteria Decision Analysis (MCDA) to assess the value of the first pharmacological treatment for AP...

Full description

Saved in:
Bibliographic Details
Main Authors: María Reyes Abad, Carmen Alerany, Luis Ignacio Gonzalez, Olaf Neth, Concepción Payares-Herrera, Carlos Rodríguez-Gallego, Jose Luis Trillo, Kirsten H. Herrmann, Raquel Figueiredo, Alicia Gil
Format: Article
Language:English
Published: AboutScience Srl 2025-01-01
Series:Global & Regional Health Technology Assessment
Subjects:
Activated phosphoinositide 3-kinase (PI3K) δ Syndrome (APDS)
Decision-making
Multi-criteria Decision Analysis (MCDA)
Ultra-rare disease, leniolisib
Online Access:https://journals.aboutscience.eu/index.php/grhta/article/view/3199
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.aboutscience.eu/index.php/grhta/article/view/3199

Similar Items